Display Mode:

    Main content

    Health Information

    Thrombolytics for Heart Attack and Stroke

    Thrombolytics for Heart Attack and Stroke

    Skip to the navigation

    Topic Overview

    Thrombolytics are medicines that rapidly dissolve a blood clot. They are used when a blood clot causes an emergency, such as a heart attack or stroke. These clot-busting medicines help blood to flow normally again.

    Thrombolytics are used as soon as possible after a heart attack or stroke. These medicines are used in the hospital. They are typically given through a vein in the hand or arm. One example of this medicine is tissue plasminogen activator (t-PA).

    These medicines can greatly increase the risk of bleeding, so they are used only in very specific situations where the risk of bleeding can be balanced against the risks of not dissolving the blood clot rapidly.

    References

    Other Works Consulted

    • Adams HP Jr, et al. (2007). Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, 38(5): 1655-1711. Also available online: http://stroke.ahajournals.org/content/38/5/1655.full.
    • Amsterdam EA, et al. (2014). 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes. Circulation, 130(25): e344-e426. DOI: 10.1161/CIR.0000000000000134. Accessed October 24, 2014.
    • O'Gara PT, et al. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127(4): e362-e425.

    Credits

    ByHealthwise Staff
    Primary Medical Reviewer E. Gregory Thompson, MD - Internal Medicine
    Specialist Medical Reviewer Jeffrey S. Ginsberg, MD - Hematology

    Current as ofJanuary 27, 2016

    This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

    © 1995-2016 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.